The results indicate that 6-Gingerol exhibits strong binding ability to these disease targets, suggesting its potential role in regulating Alzheimer’s disease at the molecular level and cholinesterase metabolism abnormalities, cell apoptosis, and other related regulatory pathways. Here, BCHE is linked to early-onset autosomal dominant Alzheimer disease.